Immuneering Corp (IMRX)

Finanzdaten der Immuneering Corp-Aktie (IMRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	35.72%25.79	19.00	15.34	13.75	15.38
Research and Development	48.04%20.72	14.00	10.65	9.25	10.87
Operating Income/Loss	35.72%-25.79	-19.00	-15.34	-13.75	-15.38
	40.08%-24.19	-17.27	-13.46	-11.58	-14.96
Attributable To Parent	40.08%-24.19	-17.27	-13.46	-11.58	-14.96
Basic Average Shares	0.03%64.71	64.70	64.66	6.93	39.67
Diluted Average Shares	0.03%64.71	64.70	64.66	6.93	39.67
Basic Earnings Per Share	37.04%-0.37	-0.27	-0.21	-0.07	-0.38
Diluted Earnings Per Share	37.04%-0.37	-0.27	-0.21	-0.07	-0.38